Tenax Therapeutics (TENX) Other financing activities (2019 - 2026)

Tenax Therapeutics (TENX) has 7 years of Other financing activities data on file, last reported at $30000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $30000.0; the trailing twelve-month figure through Mar 2026 stood at -$6.4 million (down 265.33% YoY), and the FY2025 full-year result was $15.3 million, up 22397.06% from the prior year.
• Other financing activities grew to $30000.0 in Q1 2026, from -$1.8 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $7.9 million in Q3 2022 to a low of -$7.9 million in Q4 2022.
• A 4-year average of $11117.8 and a median of $30000.0 in 2026 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 257.32% in 2024, while the deepest fall reached 244.72% in 2024.
• Tracing TENX's Other financing activities over 4 years: stood at -$7.9 million in 2022, then soared by 93.56% to -$510311.0 in 2023, then plunged by 244.72% to -$1.8 million in 2024, then surged by 101.71% to $30000.0 in 2026.
• Business Quant data shows TENX's Other financing activities at $30000.0 in Q1 2026, -$1.8 million in Q4 2024, and -$4.7 million in Q3 2024.